RT Book, Section
A1 Staskal, Daniele F.
A1 Birnbaum, Linda S.
A2 Wallace, Robert B.
SR Print(0)
ID 1141969928
T1 Brominated Flame Retardants
T2 Maxcy-Rosenau-Last Public Health and Preventive Medicine, 15e
YR 2017
FD 2017
PB McGraw-Hill Medical
PP New York, NY
SN 9780071441988
LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1141969928
RD 2024/04/20
AB The  incidence  of  fire-related  injuries,  deaths,  and  economic  damages  has  decreased  over  the  past  25  years,  partly  because  of  fire  prevention  policies  requiring  flame  retardant  chemicals  in  many  industrial  products.  Brominated  flame  retardants  (BFRs)  have  routinely  been  added  to  consumer  products  for  several  decades  to  reduce  fire-related  incidents.  They  represent  a  major  industry  involving  high-production  chemicals  with  a  wide  variety  of  uses,  yet  all  BFRs  are  not  alike  and  often  the  only  thing  that  they  have  in  common  is  the  presence  of  bromine.  Concern  for  this  emerging  class  of  chemicals  has  been  raised  following  a  rapid  increase  of  levels  in  the  environment,  wildlife,  and  people  in  combination  with  reports  of  developmental,  reproductive  and  neurotoxicity,  and  endocrine  disruption.  Despite  these  concerns,  little  information  is  available  on  their  sources,  environmental  behavior,  and  toxicity.  Because  of  limited  knowledge,  few  risk  assessments  have  been  completed.